Skip to main content
. 2023 Dec 1;43(2):269–278. doi: 10.1007/s10096-023-04719-1

Table 4.

Antimicrobial resistance profiles of K. pneumoniae

All K. pneumoniae (n = 311) CRKP (n = 140) CSKP
(n = 171)
P (comparison between CRKP and CSKP)
Antibiotics Resistance Resistance Resistance
IPM, n (%) 140 (45.0) 140 (100.0) 0 (0.0) /
AM 311 (100.0) 140 (100.0) 171 (100.0) /
AN 115 (37.0) 114 (81.4) 1 (0.6)  < 0.001
ATM 173 (55.6) 134 (95.7) 39(22.8)  < 0.001
AMC 155 (49.8) 135 (96.4) 20 (11.7)  < 0.001
CZ 218 (70.1) 137 (97.9) 81(47.4)  < 0.001
CRO 184 (59.2) 135 (96.4) 49 (28.7)  < 0.001
CIP 193 (62.1) 136 (97.1) 57 (33.3)  < 0.001
FOX 154(50.0) 133 (95.0) 21 (12.3)  < 0.001
FEP 181(58.2) 134 (95.7) 47 (27.5)  < 0.001
GM 140(45.0) 122 (87.1) 18 (10.5)  < 0.001
LEV 179(57.6) 136 (97.1) 43 (25.1)  < 0.001
SXT 154(49.5) 113 (80.7) 41 (24.0)  < 0.001
TZP 141(45.3) 135 (96.4) 6 (3.5)  < 0.001
TM 128(41.2) 119 (85.0) 9 (5.3)  < 0.001
PB / 2 (1.4) / /
CZA / 9 (6.4) / /

AM: ampicillin; AN: amikacin; ATM: aztreonam; AMC: amoxicillin-clavulanicn acid; cefazolin; ceftriaxone; CIP: ciprofloxacin; FOX: cefoxitin; FEP: cefepime; GM: gentamicin; LEV: levofloxacin; SXT: trimethoprim/sulfamethoxazole; TZP: piperacillin/tazobactam; tobramycin; PB: polymyxin B; CZA: ceftazidime-avibactam